Survey on recent developments in automatic detection of diabetic retinopathy

Diabetic retinopathy (DR) is a disease facilitated by the rapid spread of diabetes worldwide. DR can blind diabetic individuals. Early detection of DR is essential to restoring vision and providing timely treatment. DR can be detected manually by an ophthalmologist, examining the retinal and fundus images to analyze the macula, morphological changes in blood vessels, hemorrhage, exudates, and/or microaneurysms. This is a time consuming, costly, and challenging task. An automated system can easily perform this function by using artificial intelligence, especially in screening for early DR. Recently, much state-of-the-art research relevant to the identification of DR has been reported. This article describes the current methods of detecting non-proliferative diabetic retinopathy, exudates, hemorrhage, and microaneurysms. In addition, the authors point out future directions in overcoming current challenges in the field of DR research. (C) 2021 Elsevier Masson SAS. All rights reserved.

Automated summary

Diabetic retinopathy (DR) is a disease caused by the rapid spread of diabetes worldwide and early detection and treatment are crucial. An automated system using artificial intelligence can simplify the task, and there have been advancements in research for DR identification.